A Pilot Efficacy and Safety Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects.
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Darunavir (Primary) ; Raltegravir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 07 Oct 2011 Trial phase changed from III to II as reported by ClinicalTrials.gov.
- 07 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.